Crohn's MAP Vaccine
Blood & Organ Banks · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
150 Stamford St, London, Greater London,...Website
www.crohnsmapvaccine.comRevenue
$13.9 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Crohn's MAP Vaccine
Crohn's MAP Vaccine is focused on developing a potential cure for Crohn's disease, a severe form of Inflammatory Bowel Disease affecting millions worldwide. The company is conducting clinical trials for a therapeutic vaccine targeting Mycobacterium avium subspecies paratuberculosis (MAP), which is believed to be a contributing factor to the disease. Their services include a new diagnostic test for MAP, which aids in confirming infections prior to vaccination. The intended clients are individuals suffering from Crohn's disease, as well as healthcare professionals involved in their treatment.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Crohn's MAP Vaccine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Crohn's MAP Vaccine, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Crohn's MAP Vaccine launches new products
Check out if Crohn's MAP Vaccine is spiking on competitors!
Earning: See what the market has to say on Crohn's MAP Vaccine recently announced quarterly report
Check if Crohn's MAP Vaccine has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Crohn's MAP Vaccine has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Crohn's MAP Vaccine
Click to see if Crohn's MAP Vaccine had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Crohn's MAP Vaccine as Masked Content
Find 3 more new buyers
Compare Similar Companies to Crohn's MAP Vaccine
Compare insights from companies similar to Crohn's MAP Vaccine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Crohn's MAP Vaccine
$13.9M
51-200
Private
-
-
N/A
Company Profile Activity
Activity Insights
Crohn's MAP Vaccine is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Crohn's MAP Vaccine is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Crohn's MAP Vaccine.
Crohn's MAP Vaccine Tech Stack
A closer look at the technologies used by Crohn's MAP Vaccine
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Crohn's MAP Vaccine
Sign Up For FreeTo access detailed company insights
Crohn's MAP Vaccine is focused on developing a potential cure for Crohn's disease, a severe form of Inflammatory Bowel Disease affecting millions worldwide. The company is conducting clinical trials for a therapeutic vaccine targeting Mycobacterium avium subspecies paratuberculosis (MAP), which is believed to be a contributing factor to the disease... Read More
